Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
34 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

DERM — Journey Medical Corporation Dilution Risk Tracker

Track DERM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DERM — Get alerts when the score changes →

As of October 13, 2026, Journey Medical Corporation (DERM) has a DilutionWatch DilutionScore of 34/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Journey Medical Corporation has a market capitalization of $68.30M, 11.56M shares outstanding, 71 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
0
📊Float Risk—
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for DERM.
🔔 Track DERM — Get forecast alerts →

Market Data

Market Cap$68.30M
Shares Outstanding11.56M
FloatN/A
Cash$25.64M
Debt$25.47M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore34/100DilutionWatch score record
Shares Outstanding11.56MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$68.30MMarket data cache
Cash Runway52.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 24.6% shares (2026Q1 vs prior)
71 institutional holders · 13.96M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 2.16M shares
#2 WASATCH ADVISORS LP 2.13M shares
#3 Opaleye Management Inc. 1.94M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.06M
Days to Cover13.9
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2023-03-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual DERM Dilution Snapshot

Journey Medical Corporation (DERM) has a DilutionScore of 34/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

DERM's DilutionScore has held steady at 34/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202634/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

DERM shares outstanding have increased 1.0% from 21.33M (Mar 2026) to 21.53M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 30, 202621.53M14.94M▲ 0.53%
May 27, 202621.53M14.86M▲ 0.22%
May 17, 202621.53M14.83M▲ 0.59%
May 15, 202621.53M14.74M▲ 0.80%
May 12, 202621.35M14.62M▼ 1.48%
Mar 28, 202621.33M14.84M▼ 13.04%
Mar 27, 202621.33M17.07M▲ 0.72%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track DERM Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment DERM files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking DERM — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for DERM
DERM FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.